Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this trial is to investigate if roflumilast can reduce the neutrophilic inflammation at acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). In addition, the potential benefit of roflumilast on severity and recovery periods of acute COPD exacerbations will be assessed using patient diaries and questionnaires.
Epistemonikos ID: 7a07b5c5b3742beba019052b646ee6b863ccfb19
First added on: May 10, 2024